Navigation LinksTop Biology NewsTop Medical NewsTop Biology TechnologyTop Medical Technology


Heightened Awareness, Coupled with Expanding Patient Pool, Stimulates Sleep Apnea Diagnostics and Sleep Services Market, Says Frost & Sullivan

5/16/2012
LONDON, May 16, 2012 The sleep apnea diagnostics devices market has witnessed a gradual increase in revenue due to heightened demand caused by improved awareness. The market is currently in the development phase of its life cycle, with growth largely dependent on the degree of awareness of sleep apnea and reimbursement policies. New analysis from Frost & Sullivan ( htt... [Comments]

Rubicon Genomics Launches ThruPLEX™ Family of Sample Preparation Products for Next Generation Sequencing Applications

5/16/2012
ANN ARBOR, Mich., May 16, 2012  Rubicon Genomics, Inc., a leader in the development and commercialization of sample-specific pre-analytical processes to improve the performance and capabilities of DNA and RNA analytical platforms for research and clinical testing, today announced the launch of the first product in its innovative ThruPLEX™ family of sample preparation ki... [Comments]

Patient Safety Technologies Reports First Quarter 2012 Results

5/16/2012
IRVINE, Calif., May 16, 2012  Patient Safety Technologies, Inc. (the "Company," OTCBB:PSTX, OTCQB:PSTX) today announced results for its first quarter of 2012 ended March 31st, 2012. Expanded Customer Base and Financial Highlights During the first quarter of 2012 the Company successfully implemented its SurgiCount Safety-Sponge® System in an additional 51 facilities,... [Comments]

Global Human Vaccines Industry

5/16/2012
NEW YORK, May 16, 2012  Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and _ This report analyzes the worldwide markets for Prophylatic Human Vaccines in U... [Comments]

Heska to Present at B. Riley Investor Conference

5/16/2012
LOVELAND, Colo., May 16, 2012   Heska Corporation (NASDAQ: HSKA - News), a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced it is to present at the 13th Annual B. Riley & Co. Investor Conference on Wednesday, May 23, 2012 at the Loews Santa Monica Beach Hotel, 1700 Ocean Avenue – Arcadia D in Santa Monica, Calif... [Comments]

NeuroSigma Subsidiary Acquires Thin-Film Nitinol Fabrication Patent Portfolio

5/16/2012
LOS ANGELES, May 16, 2012  NeuroSigma, Inc., a Los Angeles-based medical device company, today announced that its majority-owned subsidiary, NSVascular, Inc. (NSV), acquired a portfolio of patents and related trade secrets covering the fabrication of Thin-Film Nitinol (TFN) from TiNi Alloy Company, including U.S. Patent No. 6,746,890 entitled "Three Dimensional Thin Film Devi... [Comments]

NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels

5/16/2012
NEW ORLEANS, May 16, 2012  NuMe Health LLC, a biotechnology company developing evidence-based cobiotic™ products that modify the bacteria that live in the gastrointestinal (GI) tract to support health and well-being, today announced that it has closed a $1.5 million Series A financing.  NuMe also announced that the company is initiating a clinical trial of its lead... [Comments]

Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease

5/16/2012
SOUTH SAN FRANCISCO, Calif., May 16, 2012  Rigel Pharmaceuticals, Inc., (Nasdaq: RIGL ) is expanding its respiratory franchise by focusing on two innovative, comprehensive treatment alternatives for patients with asthma. One of these agents, R343, an inhaled SYK inhibitor, will be entering a Phase 2 clinical study later this summer in mild to moderate asthmatic patients. Th... [Comments]

Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial

5/16/2012
BLUE BELL, Pa., May 16, 2012  Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its SynCon® avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines. By design, Inovio's SynCon® flu vacc... [Comments]

Nephros Reports First Quarter 2012 Financial Results

5/15/2012
RIVER EDGE, N.J., May 15, 2012  Nephros, Inc. (OTC Bulletin Board: NEPH ), a global medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, announced today financial results for the three months ended March 31, 2012. Recent Highlights Received FDA 510(k) clearance to market hemodiafi... [Comments]

[next]
(Date:5/15/2012)... May 15 (HealthDay News) -- "Team-based care" should be ... Task Force on Community Preventive Services recommended on Tuesday. ... 77 studies that showed improvements in patients, control of ... of health professionals -- a primary care doctor supported ... health worker -- rather than a primary care doctor ...
(Date:5/15/2012)... DETROIT Patients who undergo radical surgery for ... if they,re treated in accredited teaching hospitals with ... also have medical fellowships, according to a new ... which evaluated postoperative complications in 47,100 radical prostatectomy ... those with fewer complications after the surgery were ...
(Date:5/15/2012)... undergo one of the most common treatments for prostate ... to new research by Henry Ford Hospital. , In ... of the surgeon doing the procedure mattered somewhat less ... data gathered throughout the U.S., will be presented this ... Atlanta. , It is both intuitive "practice makes ...
(Date:5/15/2012)... than men after surgical removal of part or all ... dying in the hospital, although they are more likely ... , But Henry Ford Hospital researchers who documented these ... results of the new study, based on population samples ... at the American Urological Association,s Annual Meeting in Atlanta. ...
(Date:5/15/2012)... a team of Rice University freshmen took a mousetrap ... children in the developing world. , "The goal was ... so we could prevent over-hydration and under-hydration," said Melissa ... in Pediatrics) team and a mechanical engineering major. "It,s ... the world, where conditions can be pretty primitive and ...
Breaking Medicine News(10 mins):Health News:U.S. Task Force Issues Blood Pressure Guidelines 2Health News:Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs 2Health News:Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery 2Health News:Women fare better than men, but need more blood after kidney cancer surgery 2Health News:Women fare better than men, but need more blood after kidney cancer surgery 3Health News:This 'mousetrap' may save lives 2
... 8 Allscripts-Misys Healthcare,Solutions, Inc., formerly Allscripts Healthcare ... financial results for the three and six,months ended ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) , ... six months ended November 30, 2008,include results from ...
... International, Inc.,(Nasdaq: CHDX ) ("CHDX" or "the ... and services in the People,s Republic,of China, today announced ... Conference, to be held in Shanghai on January 12th ... UBS Greater China Conference will be held at the ...
... be used when assessing traditional risk factors, experts say , , ... or "biomarkers" -- of inflammation may provide useful information when ... says. , "If you are very high or very low ... study lead author Dr. Vijay Nambi, a cardiologist at the ...
... Company,s Email Encryption business continues to drive overall performanceDALLAS, ... ZIXI ), the leader in hosted services for email ... its chief executive officer, Rick Spurr."We ended the year ... as we booked the highest orders for the year ...
... A proposal by the State of Indiana to close ... the 125,000-member American Legion Department of Indiana to revamp ... to organize and coordinate its members, nearly unanimous opposition ... $50,000 in direct and in-kind support to the home, ...
... YORK, Jan. 8 United Jewish Communities (UJC) and ... raise $10 million to address humanitarian and social needs ... support and stand in solidarity with Israelis during the ... of the Gaza Strip. The funds will enhance programs ...
Other Medicine News:Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Inflammation Markers May Help Predict Stroke Risk 2Health News:Inflammation Markers May Help Predict Stroke Risk 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...
... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ... size and angle required for large and ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
Medicine Products:
(Date:5/16/2012)...  Reportlinker.com announces that a new market ... Global Human Vaccines ... http://www.reportlinker.com/p092575/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and _ This report ... Vaccines in US$ Million by the following ... Prophylactic Vaccines. The report provides separate comprehensive ...
(Date:5/16/2012)...  NuMe Health LLC, a biotechnology company developing ... live in the gastrointestinal (GI) tract to support ... closed a $1.5 million Series A financing.  NuMe ... clinical trial of its lead cobiotic product, NM504, ... to support maintenance of healthy blood glucose levels ...
(Date:5/15/2012)... 2012  Nephros, Inc. (OTC Bulletin Board: ... developing and marketing filtration products for therapeutic applications, ... results for the three months ended March 31, ... , Received FDA 510(k) clearance to market hemodiafiltration ... and supply agreement with Medica S.p.A. , ...
Breaking Medicine Technology:Global Human Vaccines Industry 2Global Human Vaccines Industry 3Global Human Vaccines Industry 4Global Human Vaccines Industry 5Global Human Vaccines Industry 6Global Human Vaccines Industry 7Global Human Vaccines Industry 8Global Human Vaccines Industry 9Global Human Vaccines Industry 10Global Human Vaccines Industry 11Global Human Vaccines Industry 12Global Human Vaccines Industry 13Global Human Vaccines Industry 14Global Human Vaccines Industry 15Global Human Vaccines Industry 16Global Human Vaccines Industry 17Global Human Vaccines Industry 18Global Human Vaccines Industry 19Global Human Vaccines Industry 20Global Human Vaccines Industry 21Global Human Vaccines Industry 22NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 2NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels 3Nephros Reports First Quarter 2012 Financial Results 2Nephros Reports First Quarter 2012 Financial Results 3Nephros Reports First Quarter 2012 Financial Results 4Nephros Reports First Quarter 2012 Financial Results 5Nephros Reports First Quarter 2012 Financial Results 6Nephros Reports First Quarter 2012 Financial Results 7Nephros Reports First Quarter 2012 Financial Results 8Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 1Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 2Stanford led study disproves link between genetic variant risk of coronary artery disease 76224 3Stem cells shape up to their surroundings 15787 1Stem cells shape up to their surroundings 15787 2Stem cells shape up to their surroundings 15787 3Redpoint Advances Salt Enhancer Discovery Program 17542 1Redpoint Advances Salt Enhancer Discovery Program 17542 2Redpoint Advances Salt Enhancer Discovery Program 17542 3Redpoint Advances Salt Enhancer Discovery Program 17542 4
... Presented at International Conference on Malignant ... Shows Dose Dependent Single Agent Activity, BETHESDA, ... biopharmaceutical company developing novel, proprietary antibodies,for the treatment ... update of an ongoing phase 1 clinical trial ...
... Discuss Clinical, Financial ... DUBLIN, Ohio, June 4 In a move that ... of,hospital-acquired infections (HAIs), Cardinal Health announced today that,it will ... will focus on the leadership and operational issues that ...
Other Medicine Technology:Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 2Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 3Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 4Micromet's BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkin's Lymphoma 5Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 2Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 3Chasing Zero Summit Pushes for Zero Tolerance Approach to Hospital-Acquired Infections 4